Home
About Journal
Editorial Board
Instruction
Subscribe
Download
Contact Us
Chinese
中国医学创新
2023
,
Vol. 20
Issue (12)
: 43-46
DOI
: 10.3969/j.issn.1674-4985.2023.12.011
Clinical research
Current Issue
|
Archive
|
Adv Search
|
Effect of Carrilizumab Combined with Chemotherapy on Patients with Advanced Liver Cancer after D-TACE
XU Qiuping
First-author's address: Fengcheng People's Hospital, Jiangxi Province, Fengcheng 331100, China
Abstract
Figure/Table
References
Related Citation (14)
Download:
PDF
(992 KB)
HTML
(1 KB)
Export:
BibTeX
|
EndNote
(RIS)
Received:
15 November 2022
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
XU Qiuping
Cite this article:
XU Qiuping. Effect of Carrilizumab Combined with Chemotherapy on Patients with Advanced Liver Cancer after D-TACE[J]. 中国医学创新, 2023, 20(12): 43-46.
URL:
http://www.zgyxcx.com/EN/10.3969/j.issn.1674-4985.2023.12.011
OR
http://www.zgyxcx.com/EN/Y2023/V20/I12/43
[1]
YANG Fan,YANG Jun,PU Zhongjian.
Analysis of Application Value of Hepatic Artery Infusion of Elemene in the Treatment of Primary Hepatocellular Carcinoma
[J]. 中国医学创新, 2023, 20(6): 1-7.
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five Postcodes: 100055